Chemistry of carbon nanotubes D Tasis, N Tagmatarchis, A Bianco, M Prato Chemical reviews 106 (3), 1105-1136, 2006 | 5108 | 2006 |
Science and technology roadmap for graphene, related two-dimensional crystals, and hybrid systems AC Ferrari, F Bonaccorso, V Fal'Ko, KS Novoselov, S Roche, P Bøggild, ... Nanoscale 7 (11), 4598-4810, 2015 | 3377 | 2015 |
Applications of carbon nanotubes in drug delivery A Bianco, K Kostarelos, M Prato Current opinion in chemical biology 9 (6), 674-679, 2005 | 2427 | 2005 |
Addition of azomethine ylides to C60: synthesis, characterization, and functionalization of fullerene pyrrolidines M Maggini, G Scorrano, M Prato Journal of the American Chemical Society 115 (21), 9798-9799, 1993 | 1763 | 1993 |
Organic functionalization of carbon nanotubes V Georgakilas, K Kordatos, M Prato, DM Guldi, M Holzinger, A Hirsch Journal of the American chemical society 124 (5), 760-761, 2002 | 1681 | 2002 |
Excited-State Properties of C60 Fullerene Derivatives DM Guldi, M Prato Accounts of chemical research 33 (10), 695-703, 2000 | 1386 | 2000 |
Functionalized carbon nanotubes for plasmid DNA gene delivery D Pantarotto, R Singh, D McCarthy, M Erhardt, JP Briand, M Prato, ... Angewandte Chemie International Edition 43 (39), 5242-5246, 2004 | 1381 | 2004 |
Translocation of bioactive peptides across cell membranes by carbon nanotubes D Pantarotto, JP Briand, M Prato, A Bianco Chemical communications, 16-17, 2004 | 1368 | 2004 |
Cellular uptake of functionalized carbon nanotubes is independent of functional group and cell type K Kostarelos, L Lacerda, G Pastorin, W Wu, S Wieckowski, J Luangsivilay, ... Nature nanotechnology 2 (2), 108-113, 2007 | 1332 | 2007 |
Biomedical applications of functionalised carbon nanotubes A Bianco, K Kostarelos, CD Partidos, M Prato Chemical Communications, 571-577, 2005 | 1326 | 2005 |
Functionalized carbon nanotubes in drug design and discovery M Prato, K Kostarelos, A Bianco Accounts of chemical research 41 (1), 60-68, 2008 | 1316 | 2008 |
Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers R Singh, D Pantarotto, L Lacerda, G Pastorin, C Klumpp, M Prato, ... Proceedings of the National Academy of Sciences 103 (9), 3357-3362, 2006 | 1311 | 2006 |
Diverse applications of nanomedicine B Pelaz, C Alexiou, RA Alvarez-Puebla, F Alves, AM Andrews, S Ashraf, ... ACS nano 11 (3), 2313-2381, 2017 | 1305 | 2017 |
Molecular design of strong single-wall carbon nanotube/polyelectrolyte multilayer composites AA Mamedov, NA Kotov, M Prato, DM Guldi, JP Wicksted, A Hirsch Nature materials 1 (3), 190-194, 2002 | 1289 | 2002 |
Carbon nanotubes as nanomedicines: from toxicology to pharmacology L Lacerda, A Bianco, M Prato, K Kostarelos Advanced drug delivery reviews 58 (14), 1460-1470, 2006 | 1218 | 2006 |
Fullerene derivatives: an attractive tool for biological applications S Bosi, T Da Ros, G Spalluto, M Prato European journal of medicinal chemistry 38 (11-12), 913-923, 2003 | 1139 | 2003 |
Fulleropyrrolidines: A family of full-fledged fullerene derivatives M Prato, M Maggini Accounts of chemical research 31 (9), 519-526, 1998 | 1120 | 1998 |
[60] Fullerene chemistry for materials science applications M Prato Journal of Materials Chemistry 7 (7), 1097-1109, 1997 | 1111 | 1997 |
Binding and condensation of plasmid DNA onto functionalized carbon nanotubes: toward the construction of nanotube-based gene delivery vectors R Singh, D Pantarotto, D McCarthy, O Chaloin, J Hoebeke, CD Partidos, ... Journal of the American Chemical Society 127 (12), 4388-4396, 2005 | 930 | 2005 |
Promises, facts and challenges for carbon nanotubes in imaging and therapeutics K Kostarelos, A Bianco, M Prato Nature nanotechnology 4 (10), 627-633, 2009 | 878 | 2009 |